Printer Friendly

BRADLEY PHARMACEUTICALS CFO TO RESIGN

 BRADLEY PHARMACEUTICALS CFO TO RESIGN
 FAIRFIELD, N.J., /PRNewswire/ -- Bradley Pharmaceuticals, Inc.


(NASDAQ: BPRXA) announced today that Richard L. Audet will resign as chief financial officer and a director of the company. Audet will therefore not be standing for re-election as a director at the annual meeting of shareholders to be held on May 29, 1992. The board of directors of the company has not yet selected a substitute nominee but expects to fill the vacancy left by Audet during the next several months in accordance with the company's by-laws in the event a substitute nominee is not chosen prior to the annual meeting.
 Bradley Pharmaceuticals, Inc. markets and distributes over-the- counter and prescription pharmaceutical and health related products.
 -0- 5/21/92
 /CONTACT: Daniel Glassman of Bradley Pharmaceuticals, 201-882-1505/
 (BPRXA) CO: Bradley Pharmaceuticals, Inc. ST: New Jersey IN: MTC SU: PER


LR -- NY093 -- 3008 05/21/92 15:58 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 21, 1992
Words:151
Previous Article:DOUGLAS & LOMASON RESUMES REGULAR QUARTERLY DIVIDEND
Next Article:ULTIMAP CORPORATION ADDS SEVEN NEW EMPLOYEES
Topics:


Related Articles
/C O R E C T I O N -- Bradley Pharmaceuticals Earnings
BRADLEY PHARMACEUTICALS REPORTS 131 PERCENT INCREASE IN FIRST QUARTER SALES
Bradley Pharmaceuticals Announces Change to Its Board of Directors.
Bradley Pharmaceuticals Increases Its Presence at The 62nd Annual Meeting of The American Academy of Dermatology.
Bradley Pharmaceuticals Updates Fourth Quarter Earnings Information.
Bradley Pharmaceuticals Announces the Launch of Zoderm(R) Prescription Acne Treatment.
Bradley Pharmaceuticals Launches 3 New Dermatology Product Line Extensions.
Bradley Pharmaceuticals to Present at the UBS Global Life Sciences Conference.
Vote the Bradley Slate to Protect Your Investment.
Bradley Pharmaceuticals Announces Resignation of Dr. Leonard S. Jacob as Non- Executive Chair, Appointment of Seth W. Hamot as Interim Non-Executive...

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters